Healthy Individuals
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Healthy adults who are able to consent to participate in this study and who can read and understand the informed consent document.
Exclusion criteria
Exclusion criteria: Not applicable
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Presence of blood coagulation and decreased proliferative activity, and estimated dose from chromosome aberration frequency. | — |
Countries
Japan
Contacts
National Institutes for Quantum Science and Technology Department of Radiation Measurement and Dose Assessment, Institute of Radiological Sciences